Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Astrazeneca Ord Shs AZNCF

Healthcare
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and... see more

Recent & Breaking News (OTCPK:AZNCF)

Benzinga's Weekend M&A Chatter

Benzinga.com  June 5, 2016

LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer

Business Wire June 5, 2016

Durvalumab Monotherapy Demonstrates Efficacy in Urothelial Bladder Cancer

Business Wire June 5, 2016

Acquisition

UK Regulatory news services, from the LSE June 3, 2016

AZ completes US licensing agreement with Ironwood

UK Regulatory news services, from the LSE June 3, 2016

AZ LICENSES ZURAMPIC TO GR�œNENTHAL GMBH

UK Regulatory news services, from the LSE June 2, 2016

PDZ Receives Strong Support from Government

UK Regulatory news services, from the LSE June 2, 2016

Updated Agreement with West Corporation

UK Regulatory news services, from the LSE June 2, 2016

Form 8.5 (EPT/RI) - Vectura Group Plc

UK Regulatory news services, from the LSE June 1, 2016

Block listing Interim Review

UK Regulatory news services, from the LSE June 1, 2016

Total Voting Rights

UK Regulatory news services, from the LSE June 1, 2016

Publication of a Prospectus

UK Regulatory news services, from the LSE May 27, 2016

Form 8.5 (EPT/NON-RI) Rexam Plc

UK Regulatory news services, from the LSE May 27, 2016

Form 8.5 (EPT/RI) Rexam Plc

UK Regulatory news services, from the LSE May 27, 2016

Form 8.5 (EPT/RI) SABMiller Plc

UK Regulatory news services, from the LSE May 27, 2016

Main Securities Market Notice

UK Regulatory news services, from the LSE May 27, 2016

Form 8.3 - Home Retail Group Plc

UK Regulatory news services, from the LSE May 27, 2016

Form 8.3 - Rexam

UK Regulatory news services, from the LSE May 27, 2016

Directorate Change

UK Regulatory news services, from the LSE May 27, 2016

Holding(s) in Company

UK Regulatory news services, from the LSE May 27, 2016